5.32
+1.04 (+24.3%)
4.8
-0.52 (-9.77%)
ChartMill assigns a Buy % Consensus number of 73% to SNSS. The Buy consensus is the weighted average rating of the current analysts ratings.
- SNSS was analyzed by 3 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about SNSS.
- In the last month the buy percentage rose by 13 points. So the trust of analysts is improving.
- Only 3 analysts analyzed SNSS. So this is just the average opinion of a couple of analysts.
Sunesis Pharmaceutic / SNSS FAQ
How do analysts rate Sunesis Pharmaceutic (SNSS)?
The consensus rating for Sunesis Pharmaceutic (SNSS) is 73.4 / 100 . This indicates that analysts generally have a positive outlook on the stock.